Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Assets (2021 - 2026)

Tevogen's (TVGN) quarterly Assets came in at $4.9 million in Q1 2026, up 20.81% on a YoY basis from $4.1 million in Q1 2025, and up 12.27% quarter-over-quarter from $4.4 million in Q4 2025.

Analysis

Tevogen (TVGN) Assets (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Assets for 6 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Assets rose 20.81% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 20.81% YoY), and the FY2025 full-year result was $4.4 million, up 26.61% from the prior year.
  • Assets rose to $4.9 million in Q1 2026 per TVGN's latest filing, from $4.4 million in the prior quarter.
  • Across five years, Assets topped out at $357.1 million in Q4 2022 and bottomed at $3.3 million in Q2 2024.
  • Historically, Assets has averaged $90.5 million across 5 years, with a median of $4.9 million in 2026.
  • The sharpest annual moves came in 2023 and 2025: Assets tumbled 98.46% in 2023, then gained 28.97% in 2025.
  • Over 5 years, Assets stood at $357.1 million in 2022, then sank by 98.46% to $5.5 million in 2023, then slumped by 37.12% to $3.5 million in 2024, then grew by 26.61% to $4.4 million in 2025, then increased by 12.27% to $4.9 million in 2026.
  • According to Business Quant data, Assets over the past three periods registered $4.9 million, $4.4 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.50 Bn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 2.65 Bn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 915.53 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 1.75 Bn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 985.10 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 1.39 Bn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 170.30 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 3.19 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 502.87 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.92 Mn
Dec 31, 2025 4.38 Mn
Sep 30, 2025 4.49 Mn
Jun 30, 2025 4.27 Mn
Mar 31, 2025 4.07 Mn
Dec 31, 2024 3.46 Mn
Sep 30, 2024 4.29 Mn
Jun 30, 2024 3.31 Mn
Mar 31, 2024 3.36 Mn
Dec 31, 2023 5.51 Mn
Sep 30, 2023 26.41 Mn
Jun 30, 2023 26.38 Mn
Mar 31, 2023 25.47 Mn
Dec 31, 2022 357.14 Mn
Sep 30, 2022 354.54 Mn
Jun 30, 2022 352.98 Mn
Mar 31, 2022 352.83 Mn
Dec 31, 2021 352.85 Mn